Christopher Sullivan sold $202K of Avalo Therapeutics stock
By AlphaYouPublished Form 4
Sullivan Christopher Ryan
Reporting filer
Christopher Ryan Sullivan reported selling 12,394 shares of Avalo Therapeutics, Inc. for about $202K ($16.33 a share on average). Form 4 filed Sep 18, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Sep 18, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Sullivan Christopher Ryan | 2026-09-16 | M | Exercise or conversion | 12394 | 9.88 | 52,294 | 2 days | Filed terms
|
| Common Stock | Sullivan Christopher Ryan | 2026-09-16 | S | Sale | 12394 | 16.3335 | 39,900 | 2 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Sullivan Christopher Ryan | 2026-09-16 | M | Exercise or conversion | 12394 | 0 | 83,848 | 2 days | Filed terms
|
Common Stock
- Owner
- Sullivan Christopher Ryan
- Date
- 2026-09-16
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 12394
- Price
- 9.88
- Following holdings
- 52,294
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 12394
- transaction Price Per Share: 9.88
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 52294
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Sullivan Christopher Ryan
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 12394
- Price
- 16.3335
- Following holdings
- 39,900
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 12394
- transaction Price Per Share: 16.3335
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 39900
- direct Or Indirect Ownership: D
- nature Of Ownership:
Stock Option (Right to Buy) (derivative)
- Owner
- Sullivan Christopher Ryan
- Date
- 2026-09-16
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 12394
- Price
- 0
- Following holdings
- 83,848
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 9.88
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 12394
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F3
- expiration Date: 2034-08-13
- underlying Security Title: Common Stock
- underlying Security Shares: 12394
- shares Owned Following Transaction: 83848
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sullivan Christopher Ryan: Chief Financial Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
- F2: The reported securities were sold in multiple transactions at prices ranging from $15.91 to $16.65. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F3: The stock option vests 25% on March 28, 2025, and 1/36 monthly thereafter, subject to the Reporting Person's continued service on such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.